Effects on Glucose Homeostasis of Changes in Plasma Lipoproteins Induced by Nutritional and Pharmacologic Strategies

NCT05213988 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-01-28

No results posted yet for this study

Summary

The investigators aim to examine the impact of changes in plasma lipoproteins induced by nutritional and pharmacological interventions on glucose homeostasis

Conditions

  • Glucose Metabolism Disorders

Interventions

DIETARY_SUPPLEMENT

Intermittent Fasting

Intermittent fasting meal pattern

DRUG

Fibrates

Bezafibrate 400 mg/day

DIETARY_SUPPLEMENT

Low-Carbohydrate/High-Protein diet

Low-calorie, low-carbohydrate, high-protein diet

Sponsors & Collaborators

  • Azienda Ospedaliero, Universitaria Pisana

    lead OTHER

Principal Investigators

  • Andrea Natali, MD · University of Pisa

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-30
Primary Completion
2025-01-01
Completion
2025-01-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05213988 on ClinicalTrials.gov